Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells-Reference-Cited by-同舟云学术

Endogenous aryl hydrocarbon receptor promotes basal and inducible expression of tumor necrosis factor target genes in MCF-7 cancer cells

Published:2014-10 Issue:3 Volume:91 Page:390-399
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Salisbury Travis B,Tomblin Justin K.,Primerano Donald A.,Boskovic Goran,Fan Jun,Mehmi Inderjit,Fletcher Jackie,Santanam Nalini,Hurn Estil,Morris Gary Z.,Denvir James

Funder

NIH

PhRMA

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference53 articles.

1. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor;Denison;Toxicol Sci,2011

2. Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver;Dere;BMC Genomics,2011

3. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq;Lo;Toxicol Sci,2012

4. Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice;Boutros;Toxicol Sci,2009

5. Identification of stanniocalcin 2 as a novel aryl hydrocarbon receptor target gene;Harper;J Pharmacol Exp Ther,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer;Biochemical Pharmacology;2023-10

2. AHR is a master regulator of diverse pathways in endogenous metabolism;Scientific Reports;2022-10-05

3. Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression;Pharmacology & Therapeutics;2021-10

4. Aryl Hydrocarbon Receptors in Indole Derivative Treated Mice: Neuropharmacological Perspectives;Acta Medica Bulgarica;2021-04-01

5. Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression;Breast Cancer Research;2020-10-27